Advances in the diagnosis, treatment, and understanding of Parkinson's disease and parkinsonism.
Highlights from the Twentieth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders October 8, 2006, Chicago, IL. Why do substantia nigra neurons die in patients with Parkinson's disease? Dr. Weiner discusses an interesting hypothesis presented at the 2006 symposium. He also reviews some of the other meeting highlights, including reports on pathologic gambling, the under-recognition of drug-induced parkinsonism, and the latest studies on estrogen replacement therapy, deep brain stimulation, and botulinum toxin.
Weiner
William J
WJ
Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
D001905:Botulinum Toxins / Q000627:therapeutic use; D016923:Cell Death; D046690:Deep Brain Stimulation; D004421:Dystonia / Q000188:drug therapy / Q000209:etiology; D015914:Estrogen Replacement Therapy; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D020734:Parkinsonian Disorders / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*
D001905:Botulinum Toxins